Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenture Life Regulatory News (VLG)

Share Price Information for Venture Life (VLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.75
Bid: 36.00
Ask: 37.50
Change: 0.00 (0.00%)
Spread: 1.50 (4.167%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 36.75
VLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2016 LTIP adopted & Grant of Options

29 Sep 2016 07:00

RNS Number : 1354L
Venture Life Group PLC
29 September 2016
 

Venture Life Group plc

("Venture Life" or the "Company")

 

Venture Life Group plc 2016 Long Term Incentive Plan and Grant of Options to PDMRs

 

Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces that it has adopted a new Long Term Incentive Plan, the Venture Life Group plc 2016 Long Term Incentive Plan ("LTIP"). Initial grants of nominal-cost share options ("Options") over ordinary shares of 0.3p each in Venture Life Group plc ("Shares") pursuant to the LTIP were made on 28 September 2016.

 

Grant of Options

On 28 September 2016 (the "Date of Grant"), Venture Life granted Options over a total of 1,641,247 Shares to its four Executive Directors, all of whom are regarded as Persons Discharging Managerial Responsibilities ("PDMRs") for the Company.

 

Vesting of the Options is subject to continued employment and the Group meeting objective performance conditions, namely the Company's Earnings Per Share ("EPS") performance and relative Total Shareholder Return (share price performance plus dividends added back - "TSR"). Half of the Shares under an Option are subject to EPS performance conditions, and half of the Shares under an Option are subject to TSR performance conditions.

 

The first tranche of Options granted over a total of 611,598 Shares ("Grant 1") will ordinarily vest on 25 March 2018, subject to meeting the performance conditions set for the Company's EPS over the three financial years ending 31 December 2017 and TSR for the three years commencing 26 March 2015.

 

The second tranche of Options granted over a total of 1,029,649 Shares ("Grant 2") will ordinarily vest on the third anniversary of the Date of Grant, subject to meeting the performance conditions set for the Company's EPS over the three financial years ending 31 December 2018 and TSR for the three years commencing on the Date of Grant.

 

The Options are exercisable at a price of 0.3p per Share.

 

Director

Position

No. of Shares under Option - Grant 1

No. of Shares under Option - Grant 2

Combined no. of Shares under Options

Total number of Shares under options held

Jerry Randall

Chief Executive Officer

203,390

340,183

543,573

1,894,793

Gianluca Braguti

Manufacturing Director

153,971

264,237

418,208

418,208

Sharon Collins

Commercial Director

135,593

226,789

362,382

1,713,602

James Hunter

Chief Financial Officer

118,644

198,440

317,084

917,084

611,598

1,029,649

1,641,247

4,943,687

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Names 

Jerry Randall - Chief Executive Officer

Gianluca Braguti - Manufacturing Director

Sharon Collins - Commercial Director

James Hunter - Chief Financial Officer

 

2

 

Reason for the notification

a)

 

Position/status

 

See 1(a) above for positions - all classified as PDMRs of Venture Life

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

Venture Life Group plc

b)

 

LEI

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Ordinary Shares of 0.3p each in Venture Life Group plc

b)

Identification code 

 

GB00BFPM8908

c)

 

Nature of the transaction 

 

Grant of Options over Ordinary Shares pursuant to the Venture Life Group plc 2016 Long Term Incentive Plan

 

d)

 

Price and volumes

Price - nil

Volumes:

Jerry Randall - 543,573 Ordinary Shares

Gianluca Braguti - 418,208 Ordinary Shares

Sharon Collins - 362,382 Ordinary Shares

James Hunter - 317,084 Ordinary Shares

d)

 

Aggregated information 

- Aggregated volume

- Price

 N/a

 

e)

 

Date of the transaction 

28 September 2016

f)

Place of the transaction

Outside a trading venue

 

Name of authorised official of issuer responsible for making notification.

James Hunter

Company Secretary to Venture Life Group plc

 

For further information please contact:

Venture Life Group PLC

+44 (0) 1344 742870

Jerry Randall, Chief Executive Officer

 

James Hunter, Chief Financial Officer

 

 

 

Panmure Gordon (UK) Limited (Nominated Adviser and Joint Broker)

+44 (0) 20 7886 2500

Freddy Crossley/Peter Steel/Duncan Monteith (Corporate Finance)

 

Tom Salvesen (Corporate Broking)

 

 

Turner Pope Investments (TPI) Ltd (Joint Broker)

+44 (0) 20 3621 4120

James Pope/Ben Turner

 

 

Walbrook PR

venturelife@walbrookpr.com or +44 (0) 20 7933 8780

Paul McManus/Anna Dunphy

+44 (0) 7980 541 893 / +44 (0) 7876 741 001

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFFRAIITFIR
Date   Source Headline
19th Feb 20245:18 pmRNSHolding(s) in Company
6th Feb 202410:48 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSTrading Update
20th Dec 20232:00 pmRNSHolding(s) in Company
28th Nov 202312:28 pmRNSHolding(s) in Company
22nd Nov 20234:05 pmRNSHolding(s) in Company
14th Nov 20237:00 amRNSChange of Nominated Adviser and Broker
31st Oct 20233:11 pmRNSHolding(s) in Company
17th Oct 20231:54 pmRNSHolding(s) in Company
25th Sep 20237:01 amRNSDirector/PDMR Shareholding
25th Sep 20237:00 amRNSHalf-year Report
5th Sep 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSTrading Statement
5th Jul 20237:00 amRNSPDMR Shareholdings – Grant of Awards
26th Jun 20234:48 pmRNSDirector/PDMR Shareholding
25th May 20231:54 pmRNSDirector Dealings
22nd May 20233:01 pmRNSResults of AGM
22nd May 20237:00 amRNSAGM Statement
19th May 20237:00 amRNSBoard Change
9th May 20237:00 amRNSNotice of Capital Markets Event
28th Apr 202310:05 amRNSAnnual Report and Notice of AGM
5th Apr 20231:53 pmRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSFinal Results for year ended 31 December 2022
31st Mar 20237:00 amRNSInvestor Presentation
13th Mar 20237:00 amRNSUpdate re Revolving Credit Facility
10th Mar 20232:05 pmRNSSecond Price Monitoring Extn
10th Mar 20232:00 pmRNSPrice Monitoring Extension
31st Jan 20237:00 amRNSTrading Statement
9th Jan 20237:00 amRNSLicensing and distribution agreements
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn
1st Dec 20224:37 pmRNSPrice Monitoring Extension
1st Dec 20227:00 amRNSAcquisition and trading update
10th Oct 20227:00 amRNSDirectorate Changes
23rd Sep 202211:08 amRNSInvestor Presentation
22nd Sep 20227:00 amRNSHalf-year Report
25th Jul 202212:00 pmRNSDirector/PDMR Shareholding
25th Jul 20227:00 amRNSTrading Update
20th Jun 20222:31 pmRNSResults of AGM
10th Jun 202212:21 pmRNSDirector/PDMR Shareholding
9th Jun 20225:53 pmRNSAnnual Report & Notice of AGM - Correction
7th Jun 20227:00 amRNSAnnual Report & Notice of AGM
30th May 20224:22 pmRNSDirector/PDMR Shareholding
30th May 20227:00 amRNSDirectorate Changes
23rd May 20224:27 pmRNSHolding(s) in Company
20th May 20227:00 amRNSInvestor Presentation
17th May 20227:00 amRNSDirectorate Changes
17th May 20227:00 amRNSFinal Results
10th May 202211:31 amRNSExercise of Share Options & Voting Rights
19th Apr 20227:00 amRNSReporting Update
23rd Mar 20223:00 pmRNSAnnouncement re: Full year results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.